Tutte le Categorie

Total voting rights

31 OCTOBER 2025 NORTHERN 2 VCT PLCTOTAL VOTING RIGHTS In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern 2 VCT PLC (the “Company”) notifies the market that the capital of the Company as at 31 October 2025 consists of 239,707,349 ordinary shares with a nominal value of 5p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in...

DXS International plc ((AQSE: DXSP) - Final Results

DXS INTERNATIONAL PLC(AQSE: DXSP)ANNUAL RESULTSfor the year ended 30 April 2025The Board of DXS International plc (“the Company”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce its audited Final Results for the year ended 30 April 2025. Financial highlights:Revenue increased by 5% to £3,469,917 (2024: £3,308,359). Core recurring revenue model remains resilient.Available cash at...

Tallinna Vesi's third-quarter sales reached €18.2 million

The sales of AS Tallinna Vesi in the third quarter of 2025 were €18.2 million, increasing 10.8% compared to the same period last year. Revenue growth was most affected by a change in price due to the need for critical investments. Aleksandr Timofejev, CEO of Tallinna Vesi, said that the third quarter was characterised by continued progress with planned investments and a commitment to the continuity of the vital service. "Summer is the busiest time of year for water and sewer pipeline...

Transaction in Own Shares

LEI: 213800NNT42FFIZB1T09 31 October 2025 Transactions in Own Shares Foresight Group Holdings Limited ("Foresight", the "Group"), a leading investment manager in real assets and providing capital for growth, announces that, in accordance with the terms of its new share buyback programme announced on 10 April 2025 (the “Share Buyback”), the Group purchased the following number of its ordinary shares of £nil par value (“Ordinary Shares”) each through JOH Berenberg, Gossler…

Mycenax and RIN Sign License Agreement to Advance ADC Development Using RIN's…

"We are thrilled to finalize this agreement with RIN Institute, marking an important milestone in our mission to provide innovative and competitive ADC solutions," said Pei-Jiun Chen, CEO and President of Mycenax. "This collaboration further enhances our technical capabilities and reinforces our commitment to advancing next-generation ADC therapeutics." "We are thrilled to finalize this agreement with RIN Institute, marking an important milestone in our mission to…

Total voting rights

31 OCTOBER 2025 NORTHERN VENTURE TRUST PLCTOTAL VOTING RIGHTS In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern Venture Trust PLC (“the Company”) notifies the market that the capital of the Company as at 31 October 2025 consists of 216,925,150 ordinary shares with a nominal value of 25p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of...

Credit Agricole Sa: End of Crédit Agricole S.A.’s share repurchase program

Press release Montrouge, October 31 st, 2025 End of Crédit Agricole S.A.’s share repurchase programCrédit Agricole S.A.’s share repurchase program, which started on 1 October 2025, was fully completed on 30 October 2025. As of 30 October 2025, 22,886,191 shares of Crédit Agricole S.A. have been purchased pursuant to the irrevocable instruction given to an independent investment services provider, for an aggregate purchase price of 374,414,014 euros. Such irrevocable instruction was...

Total voting rights

31 OCTOBER 2025 NORTHERN 3 VCT PLCTOTAL VOTING RIGHTS In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern 3 VCT PLC (the “Company”) notifies the market that the capital of the Company as at 31 October 2025 consists of 147,737,417 ordinary shares with a nominal value of 5p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in...

Facephi Reports Solid 1H25 Results, Expects Strong Acceleration in 2H25, and…

Facephi Reports Solid 1H25 Results, Expects Strong Acceleration in 2H25, and Provides 2025–2026 Financial GuidancePositive Free Cash Flow (+€0,01 mm) over the last 12 months in terms of constant currency (CC); representing an unprecedented milestone in the Company’s history.EBITDA near break-even, with a result of -€0,2 mm or +€0,1 mm in CC; showing a significant improvement compared to -€2,7 mm in H1 2024.Financial Projections 2025–2026: Revenue and EBITDA are expected to grow by...

Trading update 30 September 2025

STRONG THIRD QUARTER DRIVES RESULTS TOWARDS THE UPPER END OF THE ANNOUNCED PROFIT OUTLOOK• Increase in net rental income by 16.3% to € 55.8M (€ 48.0M at 30 September 2024); • Increase of the net result from core activities per share of 16.4% to € 4.11 at 30 September 2025 (€ 3.53 at 30 September 2024); • Increase of the fair value of the investment property portfolio (+10.4% compared to 31 December 2024); • Decrease in net asset value per share to € 79.26 due to dilution...

McKay Brothers Receives Minority Investments from Optiver and Qube

Stéphane Tyč said: "We are delighted that Optiver and QRT, long-time and highly valued customers, are backing McKay's mission to provide our services on an equal footing to market participants, large and small. The investment also bolsters our already strong financial position and supports our commitment to innovation and technical excellence." Stéphane Tyč said: "We are delighted that Optiver and QRT, long-time and highly valued customers, are backing McKay's mission to provide…

Transaction in Own Shares

ICG Enterprise Trust plc (the “Company”) 31 October 2025 Transaction in Own Shares The Company announces that on 30 October 2025 it bought back 10,000 of its own shares, to be held as treasury shares, at an average price of 1582 pence per share.Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 764,722.Total shares in issue excluding treasury shares following settlement of this purchase: 62,789,470. The Company has...

OSB GROUP PLC - Transaction in Own Shares

OSB GROUP PLC ISIN: GB00BLDRH360 31 October 2025LEI number: 213800ZBKL9BHSL2K459OSB GROUP PLC (the “Company”)Transaction in Own Shares The Company announces that on 30 October 2025 it had purchased a total of 142,086 of its ordinary shares of £0.01 each (the " ordinary shares ") on the London Stock Exchange, CBOE BXE and CBOE CXE, through the Company's broker Citigroup Global Markets Limited as detailed below. The repurchased ordinary...

Transaction in Own Shares

Irish Continental Group plc announces that it has made purchases of its own shares on the market as follows:Date of Transaction: 30 thOctober 2025.Number of Shares: 1,545,000 (one million, five hundred and forty-five thousand) ICG Units, representing 0.98% of the issued share capital prior to purchase.Price: All purchased at €5.75 per ICG Unit.These shares will be cancelled.END. Dublin 31 stOctober 2025

Kalmar's interim report January–September 2025: Improved profitability in the…

KALMAR CORPORATION, INTERIM REPORT JANUARY–SEPTEMBER 2025, 31 OCTOBER 2025 AT 9:00 AM (EET) Kalmar's interim report January–September 2025: Improved profitability in the quarterRecord-high comparable operating profit margin of 13.8 percent, supported by Services and improved efficiencyGlobal market uncertainty persisted, volatility in the tariff and trade policy landscape dampened decision-makingSolid performance in Services with both increased orders received and profitability...

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare…

$71 million in funding would extend Nanobiotix cash visibility into early 2028Transaction enables Nanobiotix development beyond key milestones in head and neck cancer and lung cancerFinancing establishes financial foundation toward self-sustainability and the advancement of next wave nanotherapeutic platforms for long-term growthHealthCare Royalty (HCRx) will receive a capped portion of milestones and royalties on sales of JNJ-1900 (NBTXR3) payable to Nanobiotix under its global...

Digitalist Group Plc’s Business Review, 1 January – 30 September 2025

Digitalist Group Plc’s Business Review, 1 January – 30 September 2025 SUMMARY July–September 2025 (comparable figures for 2024 in parentheses): Turnover: EUR 3.3 million (EUR 3.6 million), decrease: -6.7%. EBITDA: EUR -0.6 million (EUR -0.2 million), -18.8% of turnover (-5.0%).EBIT: EUR -0.8 million (EUR -0.3 million), -22.7% of turnover (-8.7%). Net income: EUR -1.5 million (EUR -1.5 million), -45.7% of turnover (-40.8%).Earnings per share: EUR -0.54 (EUR -0.52).*...

Correction: Bioretec Ltd's Half-year report 2025

The adjustment and restatement is related to the sales and distribution agreement with Tri-State Biologics ("TSB"), originally announced on 22 November 2024 (the "TSB Distribution Agreement"). The TSB Distribution Agreement was, upon its signing, based on a stocking distribution model, whereby TSB first purchases products from Bioretec for further sale and distribution by TSB to hospitals in the target geography. Following the signing of the TSB Distribution Agreement, a…

ROTOBOOST Teams with Baowu - World's Largest Steelmaker - to Industrialize…

Why it matters Why it matters Steel and aluminum are foundational yet hard to abate. The partnership pairs Baowu's process leadership with ROTOBOOST's TÜV SÜD–certified TCD platform to deliver on-site hydrogen and monetize solid carbon—cutting emissions with compelling unit economics. About the technology ROTOBOOST's TCD splits natural gas into hydrogen-rich gas and solid carbon without direct process CO₂. Modular systems enable on-demand hydrogen and production-grade carbon...

Tetragon Financial Group Limited September 2025 Monthly Factsheet

Please click below to access the Monthly Factsheet. Please click below to access the Monthly Factsheet. September 2025Factsheet About Tetragon: Tetragon is a Guernsey closed-ended investment company. Its non-voting shares are listed on Euronext inAmsterdam, a regulated market of Euronext Amsterdam N.V., and also traded on the Specialist Fund Segment of the Main Market of the London Stock Exchange. Our investment manager is Tetragon Financial Management LP. Find out more at...

VusionGroup : VusionGroup announces a strategic partnership with DM to…

October 31, 2025 – VusionGroup, the global leader in digitalization solutions for physical commerce, announces a strategic partnership with DM, Germany's leading drugstore retailer, to deploy the innovative EdgeSense digital shelf platform, that integrates centralized communication, localization and connectivity as part of a phased rollout…

New member of the Executive Management team of Realkredit Danmark A/S

Company announcement number 86/2025 - 31. October 2025New member of the Executive Management team of Realkredit Danmark A/SRealkredit Danmark adds a new member to its Executive Management team. Thais Lærkholm will join the Executive Management team of Realkredit Danmark A/S with effect from 1 January 2026.Thais Lærkholm Jensen has been part of the Danske Bank Group since 2023, when he started as Head of Products at Realkredit Danmark. He has previously held senior management roles at...

Vistin Pharma ASA: Third quarter and YTD 2025 financial results

Vistin Pharma ASA: Third quarter and YTD 2025 financial results Oslo, Norway, 31 stof October 2025Vistin Pharma ASA (VISTN) today announces the financial results for the third quarter of 2025.Revenue in the third quarter ended at MNOK 109 compared to MNOK 106 in Q3 2024. The increase in revenue was driven by 10% higher sales volume. Revenue YTD 2025 ended at MNOK 342 compared to MNOK 316 YTD last year, an increase of 8%Third quarter EBITDA ended at MNOK 28 compared to MNOK 29 in Q3...

Aalberts N.V.: Aalberts completes acquisition of Grand Venture Technology…

Utrecht, 31 October 2025Aalberts completes acquisition of Grand Venture Technology Limited Aalberts announces successful completion of the acquisition of Grand Venture Technology Limited (GVT). With its head office in Singapore, GVT operates six facilities across Singapore, Malaysia and China, generating an annual revenue of SGD 160 million in 2024 and an adjusted EBITDA margin of 19% with approximately 1,800 employees.In July 2025, Aalberts announced that an agreement was reached for...

Altri Comunicati